Skip to main content

Publicaciones científicas - Enero a Febrero de 2024

Artículos publicados de Enero a Febrero de 2024

  • Matuozzo, D., Talouarn, E., Marchal, A., Zhang, P., Manry, J., Seeleuthner, Y., Zhang, Y., Bolze, A., Chaldebas, M., Milisavljevic, B., Gervais, A., Bastard, P., Asano, T., Bizien, L., Barzaghi, F., Abolhassani, H., Tayoun, A. A., Aiuti, A., Darazam, I. A., … Martínez-Picado, J., … NIAID-USUHS, C. S. G. (2024). Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine (2023) 15 1 (22)). Genome Medicine, 16(1), 6. https://doi.org/10.1186/s13073-023-01278-0

  • Mitjà, O., Suñer, C., Giacani, L., Vall-Mayans, M., Tiplica, G. S., Ross, J. D. C., & Bradshaw, C. S. (2023). Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium, and syphilis. Lancet Regional Health-Europe, 34, Article 100737. https://doi.org/10.1016/j.lanepe.2023.100737

  • Mauri-Obradors, E., & Elosua, R. (2024). The oral-systemic axis: how oral health affects cardiovascular and metabolic health. European Journal of Preventive Cardiology, 31(1), 11-12. https://doi.org/10.1093/eurjpc/zwad353 

  • Elosua, R., Toloba, A., Arnold, R., De Groot, E., Martí-Lluch, R., Román Dégano, I., Marrugat, J., & Ramos, R. (2024). Rigidez carotídea y riesgo de eventos vasculares y mortalidad: el estudio REGICOR. Revista Española de Cardiología. https://doi.org/10.1016/j.recesp.2023.09.005

  • Bastard, P., Vazquez, S. E., Liu, J., Laurie, M. T., Wang, C. Y., Gervais, A., Voyer, T. L., Bizien, L., Zamecnik, C., Philippot, Q., Rosain, J., Catherinot, E., Willmore, A., Mitchell, A. M., Bair, R., Garçon, P., Kenney, H., Fekkar, A., Salagianni, M., … Martínez-Picado, J., … COMET Consortium. (2023). Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Science Immunology, 8(90). https://doi.org/10.1126/sciimmunol.abp8966

  • Chen, S., Francioli, L. C., Goodrich, J. K., Collins, R. L., Kanai, M., Wang, Q., Alföldi, J., Watts, N. A., Vittal, C., Gauthier, L. D., Poterba, T., Wilson, M. W., Tarasova, Y., Phu, W., Grant, R., Yohannes, M. T., Koenig, Z., Farjoun, Y., Banks, E., … Elosua, R., … Genome, A. D. C. (2024). A genomic mutational constraint map using variation in 76,156 human genomes. Nature, 625(7993), 92-100. https://doi.org/10.1038/s41586-023-06045-0

  • Elosua, R. (2023). Cirugía, intervencionismo coronario y mortalidad: algunos aspectos metodológicos. Revista Española de Cardiología.  https://doi.org/10.1016/j.recesp.2023.11.015

  • Wiessing, L., Banka-Cullen, P., Barbaglia, M. G., Belackova, V., Belbaisi, S. A. S., Blanken, P., Carrieri, P., Comiskey, C., Dacosta-Sánchez, D., Dom, G., Fabricius, V., Faria, H., Ignjatova, L., Inić, N., Jacobsen, B., Javakhishvili, J. D., Kamendy, Z., Kapitány-Fövény, M., Kiss, A., …Torrens, M., Walley, A. Y., Yiasemi, I. (2023). Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report. International Journal of Mental Health and Addiction.  https://doi.org/10.1007/s11469-023-01213-9

  • Ávila-Nieto, C., Vergara-Alert, J., Amengual-Rigo, P., Ainsua-Enrich, E., Brustolin, M., Rodríguez de la Concepción, M. L., Pedreño-Lopez, N., Rodon, J., Urrea, V., Pradenas, E., Marfil, S., Ballana, E., Riveira-Muñoz, E., Pérez, M., Roca, N., Tarrés-Freixas, F., Carabelli, J., Cantero, G., Pons-Grífols, A., … Blanco, J., Clotet, B., Carrillo, J.  (2023). Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant. Frontiers in Immunology, 14, 1291972.  https://doi.org/10.3389/fimmu.2023.1291972

  • Chen, S., Francioli, L. C., Goodrich, J. K., Collins, R. L., Kanai, M., Wang, Q., Alföldi, J., Watts, N. A., Vittal, C., Gauthier, L. D., Poterba, T., Wilson, M. W., Tarasova, Y., Phu, W., Grant, R., Yohannes, M. T., Koenig, Z., Farjoun, Y., Banks, E., … Elosua, R., … Genome, A. D. C. (2024). A genomic mutational constraint map using variation in 76,156 human genomes. Nature, 625(7993), 92-100. https://doi.org/10.1038/s41586-023-06045-0

  • Nguyen, B. T., Marc, A., Suñer, C., Marks, M., Ubals, M., Hernández-Rodríguez, Á., Melendez, M. Á., Hruby, D. E., Russo, A. T., Mentré, F., Mitjà, O., Grosenbach, D. W., Guedj, J., & The, M. G. (2023). Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection. PLoS Biology, 21(12). https://doi.org/10.1371/journal.pbio.3002249

  • Martín Mojarro, E., Gil, V., Llorens, P., Álvarez, J., Flores Quesada, S., Troiano Ungerer, O. J., Alquézar-Arbé, A., Jacob, J., Herrero-Puente, P., Espinosa, B., Sánchez, C., Llauger, L., Tost, J., Serrano, L., Dávila, A., Torres Garate, R., López-Grima, M. L., Lucas-Imbernón, F. J., Alonso, H., … Grupo de investigacion ICA-SEMES. (2023). Uso de digoxina endovenosa en urgencias para tratar pacientes con insuficiencia cardiaca aguda y su impacto en la evolución a corto plazo. Emergencias : Revista de la Sociedad Española de Medicina de Emergencias, 35(6), 437-446. https://tuit.cat/P7GSa

  • Cambra-Badii, I. (2023). The Challenge of Teaching Bioethics. En Bioethics: Foundations, Applications and Future Challenges (pp. 183-200). https://doi.org/10.1201/9781003269885-14

  • Cambra-Badii, I., Busquets-Alibés, E., Terribas-Sala, N., & Baños, J.-E. (2023). Preface. Bioethics: Foundations, Applications and Future Challenges, iii-vii. https://tuit.cat/7Fzq3

  • Farré, M., & Baños, J.-E. (2023). Bioethics in Biomedical Research. En Bioethics: Foundations, Applications and Future Challenges (pp. 53-71). https://doi.org/10.1201/9781003269885-6

  • Baños, J.-E., & Guardiola, E. (2023). History of Bioethics. En Bioethics: Foundations, Applications and Future Challenges (pp. 19-32). https://doi.org/10.1201/9781003269885-3

  • Cambra-Badii, I., Busquets-Alibés, E., Terribas-Sala, N., & Baños, J.-E. (2023). Bioethics: Foundations, Applications and Future Challenges (p. 204). https://doi.org/10.1201/9781003269885

  • Espaulella-Ferrer, M., Morel-Corona, F. J., Zarco-Martinez, M., Marty-Perez, A., Sola-Palacios, R., Campollo-Duquela, M. E., Cruz-Grullon, M., Puigoriol-Juvanteny, E., Otero-Viñas, M., & Espaulella-Panicot, J. (2023). Health care model for people living in nursing homes based on integrated care. Journal of Integrated Care. https://doi.org/10.1108/JICA-07-2023-0059

  • Suridjan, I., van der Flier, W. M., Monsch, A. U., Burnie, N., Baldor, R., Sabbagh, M., Vilaseca, J., Cai, D., Carboni, M., & Lah, J. J. (2023). Blood-based biomarkers in Alzheimer’s disease: Future directions for implementation. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 15(4). https://doi.org/10.1002/dad2.12508

  • Vidal-Alaball, J., Panadés Zafra, R., Escalé-Besa, A., & Martinez-Millana, A. (2024). The artificial intelligence revolution in primary care: Challenges, dilemmas and opportunities. Atención Primaria, 56(2).  https://doi.org/10.1016/j.aprim.2023.102820

  • Lladós, G., Massanella, M., Coll-Fernández, R., Rodríguez, R., Hernández, E., Lucente, G., López, C., Loste, C., Santos, J. R., España-Cueto, S., Nevot, M., Muñoz-López, F., Silva-Arrieta, S., Brander, C., Durà, M. J., Cuadras, P., Bechini, J., Tenesa, M., Martinez-Piñeiro, A., … Germans, T. L.-C. U. Group. (2023). Vagus nerve dysfunction in the post–COVID-19 condition: A pilot cross-sectional study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.11.007

  • Roura, P., Puigoriol, E., Altimiras, J., Batiste-Alentorn, E., & Roman Dégano, I. (2023). Trend and Joinpoint Analysis of Cancer Incidence and 1-Year Mortality in North-East Spain 2005–2020. Cancers, 15(23). https://doi.org/10.3390/cancers15235527

  • Millat-Martínez, P., Baro, B., Kasian, B., Lorry, L., Sanz, S., Wali, C., . . . Mitjà, O., Bassat, Q. (2023). A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts. Malaria Journal, 22(1), Article 364. https://doi.org/10.1186/s12936-023-04804-y

  • Mauricio, D., Gratacòs, M., & Franch-Nadal, J. (2023). Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovascular Diabetology, 22(1), 314. https://doi.org/10.1186/s12933-023-02056-3

  • Hecht, J. R., Tabernero, J., Parikh, A. R., Wang, Y. J., Wang, Z., Schwickart, M., . . . Saeed, A. (2023). STELLAR-303: A phase 3 study of XL092 in combination with atezolizumab versus regorafenib in patients with previously treated metastatic colorectal cancer (mCRC). Journal of Clinical Oncology, 41, TPS267-TPS267. https://doi.org/10.1200/JCO.2023.41.4_suppl.TPS267

  • Colle, R., Lonardi, S., Cachanado, M., Overman, M. J., Elez, E., Fakih, M., . . . Andre, T. (2023). Impact of Lynch syndrome, BRAFV600E, and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts. Journal of Clinical Oncology, 41, 171-171. https://doi.org/10.1200/JCO.2023.41.4_suppl.171

  • Kopetz, S., Yoshino, T., Kim, T. W., Yaeger, R., Desai, J., Wasan, H. S., . . . Tabernero, J. (2023). BREAKWATER safety lead-in (SLI): Encorafenib (E) plus cetuximab (C) plus chemotherapy for BRAFV600E metastatic colorectal cancer (mCRC). Journal of Clinical Oncology, 41, 119-119. https://doi.org/10.1200/JCO.2023.41.4_suppl.119

  • Tabernero, J., Prager, G. W., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., . . . Taieb, J. (2023). Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study. Journal of Clinical Oncology, 41, 4-4. https://doi.org/10.1200/JCO.2023.41.4_suppl.4

  • Solis, E. S., Pascual, T., Torres, E. S., Gonzalez-Farre, B., Brasó-Maristany, F., Farre, X. G., . . . Tabernero, J., Prat, A. (2023). Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types. Annals of Oncology, 34, S1153-S1154. https://doi.org/10.1016/j.annonc.2023.09.1267

  • Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., . . . Tabernero, J., Rha, S. Y. (2023). Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study. Annals of Oncology, 34, S851-S852. https://doi.org/10.1016/j.annonc.2023.09.1424

  • Janjigian, Y. Y., Al-Batran, S. E., Wainberg, Z. A., Van Cutsem, E., Molena, D., Muro, K., . . . Tabernero, J. (2023). Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study. Annals of Oncology, 34, S1315-S1316. https://doi.org/10.1016/j.annonc.2023.10.074

  • Salva, F., Paes, R., Silva, M. C. E., Cruz, H., Gonzalez, N. S., Baraibar, I., . . . Tabernero, J., Elez. E., Dienstmann, R. (2023). Identification and external validation of clinical-molecular features to predict benefit from oxaliplatin reintroduction/rechallenge in patients with refractory metastatic colorectal cancer (mCRC). Journal of Clinical Oncology, 41, 153-153. https://doi.org/10.1200/JCO.2023.41.4_suppl.153

  • Kopetz, S., Bekaii-Saab, T. S., Yoshino, T., Chung, C. H., Zhang, X. S., Tabernero, J. (2023). SEAMARK: Randomized phase 2 study of pembrolizumab plus encorafenib plus cetuximab vs pembrolizumab alone for first-line treatment of BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC). Journal of Clinical Oncology, 41 (4), TPS268-TPS268.

  • Dienstmann, R. (2023). Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials. Annals of Oncology, 34(11), 962-963.  https://doi.org/10.1016/j.annonc.2023.10.002

  • Segura, S., Podlipnik, S., Boada, A., Martí, R. M., Sabat, M., Yélamos, O., Zarzoso-Muñoz, I., Azón-Masoliver, A., López-Castillo, D., Solà, J., Baliu-Piqué, C., Galvany-Rossell, L., Pasquali, P., Just-Sarobé, M., Duran, X., Carrera, C., Richarz, N. A., Pujol, R. M., Malvehy, J., & Puig, S. (2023). Melanoma-specific survival is worse in the elderly: A multicentric cohort study. Melanoma Research, 33(6), 532-538. https://doi.org/10.1097/CMR.0000000000000923

  • Martínez-Moreno, R., Pérez-Serra, A., Selga, E., Carreras, D., Aran, B., Kuebler, B., Scornik, F. S., Pérez, G. J., & Brugada, R. (2023). Generation of the induced pluripotent stem cell line ESi108-A from a familial atrial fibrillation patient. Stem Cell Research, 73.https://doi.org/10.1016/j.scr.2023.103239

  • Garcia-Pérez, D., Vena-Martínez, A., Robles-Perea, L., Rosello-Padulles, T., Espaulella-Panicot, J., & Arnau, A. (2023). Prognostic Value of a New Tool (the 3D/3D+) for Predicting 30-Day Mortality in Emergency Department Patients Aged 75 Years and Older. Journal of Clinical Medicine, 12(20), Article 6469. https://doi.org/10.3390/jcm12206469

  • Esteban-Burgos, A. A., Hueso-Montoro, C., Mota-Romero, E., Montoya-Juarez, R., Gomez-Batiste, X., & Garcia-Caro, M. P. (2023). The prognostic value of the NECPAL instrument, Palliative Prognostic Index, and PROFUND index in elderly residents of nursing homes with advanced chronic condition. Bmc Geriatrics, 23(1), Article715. https://doi.org/10.1186/s12877-023-04409-9

  • Jerez-Roig, J.,Bezerra de Souza, D.L, Cambra-Badii, I., March-Amengual, J.M., Comella, A., Masó Aguado, M., Ramon-Aribau, A., Luque-Suárez, A., Feito Grande, L., Terribas, N., Vivanco, L., Busquets-Alibés, E. (2023). Change in demand for health-related undergraduate studies in Spain during 2015-2021: a temporal series study. PeerJ, 11, num: 16353. https://doi.org/10.7717/peerj.16353

  • Pujol Farriols, R., & Guanyabens Calvet, J. (2023). La medicina en tiempos de inteligencia artificial. Medicina Clinica. https://doi.org/10.1016/j.medcli.2023.09.007

  • Vokes, E. E., Mornex, F., Sezer, A., Cheng, Y., Fang, J., Baz, D. V., Cil, T., Adjei, A. A., Ahn, M.-J., Barlesi, F., Felip, E., Garon, E. B., Audhuy, F., Ito, R., Sato, M., Eggleton, S. P., Martin, C. M., Reck, M., Robinson, C. G., & Paz-Ares, L. (2023). Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study. Journal of Thoracic Oncology.  https://doi.org/10.1016/j.jtho.2023.09.1452

  • Tantalo, L. C., Lieberman, N. A. P., Pérez-Mañá, C., Suñer, C., Vall Mayans, M., Ubals, M., González-Beiras, C., Rodríguez-Gascón, A., Canut, A., González-Candelas, F., Mueller, J., Tapia, K., Greninger, A. L., Giacani, L., & Mitjà, O. (2023). Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: An in-vitro study. The Lancet Microbe. https://doi.org/10.1016/S2666-5247(23)00219-7

  • Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., Yanez, P., Wyrwicz, L. S., Shen, L., Ostapenko, Y., Bilici, M., Chung, H. C., Shitara, K., Qin, S.-K., Van Cutsem, E., Tabernero, J., Li, K., Shih, C.-S., Bhagia, P., … KEYNOTE-811, I. (2023). Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/S0140-6736(23)02033-0

  • Lozano-Rodríguez, R., Avendaño-Ortíz, J., Montalbán-Hernández, K., Ruiz-Rodríguez, J. C., Ferrer, R., Martín-Quirós, A., Maroun-Eid, C., González-López, J. J., Fàbrega, A., Terrón-Arcos, V., Gutiérrez-Fernández, M., Alonso-López, E., Cubillos-Zapata, C., Fernández-Velasco, M., Pérez de Diego, R., Pelegrin, P., García-Palenciano, C., Cueto, F. J., del Fresno, C., & López-Collazo, E. (2023). The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis. eBioMedicine, 97. https://doi.org/10.1016/j.ebiom.2023.104841

  • Sánchez-Vera, I., Saura-Esteller, J., Núñez-Vázquez, S., Cosialls, A. M., Ghashghaei, O., Lavilla, R., Pons, G., Gil, J., & Iglesias-Serret, D. (2023). The prohibitin-binding compound fluorizoline induces the pro-inflammatory cytokines interleukin-8 and interleukin-6 through the activation of JNK and p38 MAP kinases. Biochemical Pharmacology, 218. https://doi.org/10.1016/j.bcp.2023.115860

  • Soto-Araya, M., Baños, J. E., Moyano, E., & Pérez, J. (2023). La Presencia de las Humanidades en las Carreras de Odontología de las Universidades de Chile y de España. Revista de Medicina y Cine, 19(3), 237-247. https://doi.org/10.14201/rmc.31418

¿No encuentras lo que buscas?

Contáctanos

Si tienes alguna pregunta, nosotros tenemos la respuesta

Contacto